SOLICITATION NOTICE
B -- IDIQ for the purchase of human induced pluripotent stem cell-derived cells
- Notice Date
- 4/9/2025 9:34:49 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- FDASS126983
- Response Due
- 5/2/2025 7:00:00 AM
- Archive Date
- 05/17/2025
- Point of Contact
- Telisha Wilson
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- 8AN 8(a) Sole Source (FAR 19.8)
- Description
- Notice of Intent to Sole Source Solicitation Number: FDA - Sole Source - 126983 Posted Date: April 09, 2025 Questions Due Date: 10AM EST on April 21, 2025 Response Date: 10AM EST May 02, 2025 NAICS Code: 541714-Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/4a54b7666e5c4f5386a618d79860369e/view)
- Record
- SN07402309-F 20250411/250409230052 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |